Baltimore Settles Opioid Lawsuit with Allergan for $45M

Baltimore Settles Opioid Lawsuit with Allergan for $45M

Introduction

Baltimore has announced a $45 million settlement with Allergan Finance LLC to resolve the ongoing opioid lawsuit against the company.

This significant settlement results from the city opting out of previous global settlements, which would have provided only $7 million over seven years. Instead, the new agreement requires Allergan to pay the entire $45 million within 30 days.

Baltimore City Comptroller praised the settlement, emphasizing the importance of receiving the full amount upfront. This settlement exceeds any previous agreements Allergan has made with other states, including Maryland, which settled for $38 million earlier this year.

Baltimore Mayor commented on the historic settlement, acknowledging the severe impact of the opioid crisis on the city and the importance of holding the responsible parties accountable. The mayor emphasized that all recovered funds will be used effectively to combat the opioid epidemic at every level in Baltimore.

Baltimore City Councilman also highlighted the settlement's significance, noting that while it cannot bring back those lost to the crisis, it is a critical step forward. He announced the creation of a board to oversee the allocation of opioid settlement funds. Further details about the board are forthcoming, but $10 million has already been earmarked for outreach programs, including "peer navigators," which involve individuals in recovery helping others.

The councilman stressed the impact of the funds on recovery programs, stating that they will make a substantial difference for those in recovery who are now able to assist others. The funds will support these crucial programs, enhancing their ability to help those affected by the opioid crisis.

Baltimore City Chief Administrative Officer expressed optimism about the settlement, indicating that this $45 million is just the beginning. He anticipates additional settlements in the hundreds of millions, if not billions, to further aid the city in repairing the damage caused by opioid manufacturers.

This settlement represents a major step in Baltimore's efforts to address the opioid crisis and hold accountable those responsible for its devastating effects on the community. The city's proactive approach and significant recovery funds underscore its commitment to combating the epidemic and supporting recovery efforts.